Goel, M KGoel, MKhanna, PMittal, K2012-12-112012-12-112011-01Goel M K, Goel K, Khanna P, Mittal K. Pandemic influenza A (H1N1) 2009 vaccine: An update. Indian Journal of Medical Microbiology. 2011 Jan-Mar; 29(1): 13-18.http://imsear.searo.who.int/handle/123456789/143768The world witnessed a the first influenza pandemic in this century and fourth overall since first flu pandemic was reported during the World War I. The past experiences with influenza viruses and this pandemic of H1N1 place a consider­able strain on health services and resulted in serious illnesses and a large number of deaths. Develop­ing countries were declared more likely to be at risk from the pandemic effects, as they faced the dual problem of highly vulnerable populations and limited resources to respond H1N1. The public health experts agreed that vaccination is the most effective ways to mitigate the negative effects of the pandemic. The vaccines for H1N1 virus have been used in over 40 coun­tries and administered to over 200 million people helped in a great way and on August 10, 2010, World Health Organization (WHO) announced H1N1 to be in postpandemic period. But based on knowledge about past pandemics, the H1N1 (2009) virus is expected to continue to circulate as a seasonal virus and may undergo some agenic-variation. As WHO strongly recommends vaccination, vigilance for regular updating of the composition of influenza vaccines, based on an assessment of the future impact of circulating viruses along with safety surveillance of the vaccines is necessary. This review has been done to take a stock of the currently available H1N1 vaccines and their possible use as public health intervention in the postpandemic period.enInfluenza A (H1N1)H1N1 vaccinespostpandemicpandemicIndiaArticle